RXST FY 2023 Earnings — RxSight, Inc. Revenue & Financial Results | Market Cap Arena

RXSTRxSight, Inc.

$313M

FY 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$89M+81.8% YoY

Gross Profit

$54M60.4% margin

Operating Income

-$50M-56.2% margin

Net Income

-$49M-54.6% margin

EPS (Diluted)

$-1.41

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$46M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$183M

Total Liabilities

$22M

Stockholders' Equity

$160M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$89M	$49M	+81.8%
Gross Profit	$54M	$21M	+152.1%
Operating Income	-$50M	-$63M	+20.9%
Net Income	-$49M	-$67M	+27.2%